Amplitude Surgical SAS Cash Flow Conversion Efficiency
Amplitude Surgical SAS cash flow conversion efficiency. Based on the latest financial reports, Amplitude Surgical SAS (AMPLI) has a cash flow conversion efficiency ratio of 0.029x as of December 2024. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€2.77 Million ≈ $3.24 Million USD) by net assets (€94.70 Million ≈ $110.71 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Amplitude Surgical SAS (2011–2024)
Cash flow conversion efficiency of Amplitude Surgical SAS from 2011 to 2024. This chart illustrates how Amplitude Surgical SAS's cash flow conversion efficiency has evolved over time, based on yearly financial data. View AMPLI stock price for real-time trading data and today's change.
Amplitude Surgical SAS Cash Flow Conversion Ratio Explained
Amplitude Surgical SAS cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Amplitude Surgical SAS Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Amplitude Surgical SAS ranked by their cash flow conversion efficiency. Also see Amplitude Surgical SAS market capitalisation for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
908 Devices Inc
NASDAQ:MASS
|
0.008x |
|
Vinacafe Bien Hoa JSC
VN:VCF
|
-0.043x |
|
MOZAYYX Acquisition Corp.
NYSE:MZYX
|
-0.001x |
|
Five Point Holdings LLC
NYSE:FPH
|
-0.004x |
|
Colonial Coal International Corp
V:CAD
|
-0.023x |
|
Transcontinental Inc
TO:TCL-A
|
-0.095x |
|
Shenzhen Kexin Communication Technologies Co Ltd
SHE:300565
|
-0.061x |
|
Websol Energy System Limited
NSE:WEBELSOLAR
|
0.338x |
Annual Cash Flow Conversion Efficiency for Amplitude Surgical SAS (2011–2024)
The table below shows the annual cash flow conversion efficiency of Amplitude Surgical SAS from 2011 to 2024. Review Amplitude Surgical SAS (AMPLI) free cash flow to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-06-30 | €95.82 Million ≈ $112.02 Million |
€4.04 Million ≈ $4.73 Million |
0.042x | -50.07% |
| 2023-06-30 | €95.81 Million ≈ $112.02 Million |
€8.10 Million ≈ $9.47 Million |
0.084x | -44.36% |
| 2022-06-30 | €52.57 Million ≈ $61.46 Million |
€7.98 Million ≈ $9.33 Million |
0.152x | +268.42% |
| 2021-06-30 | €56.87 Million ≈ $66.48 Million |
€2.34 Million ≈ $2.74 Million |
0.041x | -76.40% |
| 2020-06-30 | €70.91 Million ≈ $82.90 Million |
€12.38 Million ≈ $14.48 Million |
0.175x | +81.15% |
| 2019-06-30 | €85.50 Million ≈ $99.95 Million |
€8.24 Million ≈ $9.64 Million |
0.096x | +1.63% |
| 2018-06-30 | €94.68 Million ≈ $110.69 Million |
€8.98 Million ≈ $10.50 Million |
0.095x | +265.03% |
| 2017-06-30 | €103.14 Million ≈ $120.58 Million |
€2.68 Million ≈ $3.13 Million |
0.026x | +54.47% |
| 2016-06-30 | €118.12 Million ≈ $138.09 Million |
€1.99 Million ≈ $2.32 Million |
0.017x | +112.09% |
| 2015-06-30 | €118.76 Million ≈ $138.84 Million |
€-16.53 Million ≈ $-19.33 Million |
-0.139x | -59.01% |
| 2014-06-30 | €22.31 Million ≈ $26.08 Million |
€-1.95 Million ≈ $-2.28 Million |
-0.088x | -1008.15% |
| 2013-06-30 | €20.44 Million ≈ $23.89 Million |
€197.00K ≈ $230.31K |
0.010x | +106.61% |
| 2012-06-30 | €22.40 Million ≈ $26.18 Million |
€-3.26 Million ≈ $-3.82 Million |
-0.146x | -8.89% |
| 2011-06-30 | €25.40 Million ≈ $29.69 Million |
€-3.40 Million ≈ $-3.97 Million |
-0.134x | -- |
About Amplitude Surgical SAS
Amplitude Surgical SA designs, develops, and markets products for orthopedic surgery in France and internationally. The company provides a range of orthopedic products for primary and revision surgery aimed at treating pathologies of the hip, knee, and lower extremities primarily for foot and ankle surgery. It also offers AMPLIVISION, a computer-assisted surgery system; the i.M.A.G.E., a single-u… Read more